This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
saas: Archive
Microsoft Stock Before Q2 Earnings: A Smart Buy or Risky Investment?
by Vasundhara Sawalka
MSFT is progressing in the cloud market, which makes the stock worth a cautious watch ahead of its fiscal Q2 earnings amid intense competition and elevated valuation.
MSFTNegative Net Change DELLNegative Net Change LNVGYPositive Net Change HPENegative Net Change
artificial-intelligence saas tech-stocks
Here's Why Zoom Stock is Still a Top Buy Despite 36% Rally in 6 Months
by Vasundhara Sawalka
ZM's AI innovation, record-low churn and strong enterprise growth make it attractive despite recent gains. With $7.7 billion cash and new buybacks, the stock looks promising.
MSFTNegative Net Change CSCOPositive Net Change ZMNegative Net Change METANegative Net Change
artificial-intelligence saas tech-stocks
After Golden Cross, USA Compression Partners (USAC)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
USACPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Coterra Energy (CTRA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bull of the Day: GitLab (GTLB)
by Kevin Cook
Another beat-and-raise quarter of enterprise growth has EPS estimates jumping 27% for the new year
GTLBPositive Net Change
artificial-intelligence cloud-computing cybersecurity saas software
Plains All American Pipeline (PAA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PAAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Palo Alto Trades at Premium Valuation: Buy, Hold or Sell the Stock?
by Anirudha Bhagat
While PANW's near-term growth may be slowing, its robust long-term potential remains compelling.
FTNTPositive Net Change PANWPositive Net Change CRWDPositive Net Change
artificial-intelligence computers cybersecurity saas software tech-stocks
Mercury Systems Jumps 29.6% in a Year: 3 Reasons to Buy the Stock Now
by Vasundhara Sawalka
Mercury Systems soars 29% in a year. Record $1.3 billion backlog and defense tech leadership make MRCY a compelling buy for 2025.
LMTNegative Net Change BAESYNegative Net Change MRCYNegative Net Change LHXPositive Net Change
aerospace saas
CrowdStrike Trades at Premium Valuation: Buy, Sell or Hold the Stock?
by Anirudha Bhagat
While CRWD's focus on innovation and a diversified product portfolio provides a strong foundation for future growth, premium valuation warrants caution.
MSFTNegative Net Change FTNTPositive Net Change CRWDPositive Net Change
artificial-intelligence computers cybersecurity saas software tech-stocks
Arc Resources (AETUF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AETUFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines